Inhibition of VEGF-A Prevents the Angiogenic Switch and Results in Increased Survival of$Apc^{+/\tex...
Inhibition of VEGF-A Prevents the Angiogenic Switch and Results in Increased Survival of$Apc^{+/\text{min}}$Mice
About this item
Full title
Author / Creator
Publisher
National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Anti-VEGF-A monoclonal antibodies, in combination with chemotherapy, result in a survival benefit in patients with metastatic colorectal and non-small cell lung cancer, but little is known regarding the impact of anti-VEGF-A therapy on benign or premalignant tumors. The$Apc^{+/\text{min}}$mice have been widely used as a model recapitulating early i...
Alternative Titles
Full title
Inhibition of VEGF-A Prevents the Angiogenic Switch and Results in Increased Survival of$Apc^{+/\text{min}}$Mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_jstor_primary_25435983
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_25435983
Other Identifiers
ISSN
0027-8424
DOI
10.1073/pnas.0704213104
